V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002569 | 240009593 | 0 | 18.7 | null | 2019-05-15 | 2019-05-17 | FLAG + Idarubicin | 02 | N | RUXOLITINIB | 100645679 |
| 240002572 | 240009594 | 1.75 | 46.4 | null | null | 2020-02-22 | Cyclophosphamide+Fludara+TBI Allo | null | null | CLADRIBINE | 101846845 |
| 240002576 | 240009596 | 1.68 | 52.2 | Curative (C) | 2020-07-02 | 2020-07-07 | Venetoclax | 02 | null | BUSULFAN | 100397262 |
| 240002580 | 240009599 | 1.72 | null | null | 2020-08-18 | 2020-09-29 | CYTARABINE + DAUNORUBICIN | 01 | null | PEG INTERFERON | 100624205 |
| 240002590 | 240009601 | 1.91 | 106.2 | null | 2021-09-21 | 2021-09-21 | null | N | N | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100767640 |
| 240002597 | 240009603 | 1.62 | 17.3 | 03 | 2018-06-19 | 2018-06-24 | FLAG + Idarubicin | 02 | null | AML INTERIM GUIDELINES FLAG-IDA | 101029319 |
| 240002604 | 240009604 | 1.82 | 85 | Curative (C) | 2017-10-27 | 2017-11-09 | ALL UKALL2011 Del Int C Recon PAsp | 02 | N | IBRUTINIB | 100898534 |
| 240002610 | 240009606 | 1.74 | null | null | 2019-08-10 | 2019-08-13 | R CODOX M | 02 | null | VENETOCLAX | 100238819 |
| 240002612 | 240009607 | 1.62 | 102.8 | null | 2021-01-30 | 2021-02-02 | ALEMTUZUMAB + FLUDARABINE + LEAM | 02 | N | ETOPOSIDE | 100396553 |
| 240002613 | 240009608 | 1.84 | 20.4 | null | 2016-04-21 | 2016-04-25 | BEAM + Alemtuzumab Allo SCT | N | null | BUSULFAN | 101654756 |
| 240002619 | 240009610 | 1.62 | 114 | Palliative (P) | 2019-07-15 | 2019-07-19 | CVP R | null | N | CNS LGG2004 03 VINC + CARBO | 101456528 |
| 240002620 | 240009611 | 0 | 44 | Curative (C) | 2020-03-20 | 2020-03-20 | AML16 DA 3+10 | 02 | N | ANAGRELIDE | 100852396 |
| 240002621 | 240009612 | 1.54 | 71 | Curative (C) | 2020-12-10 | 2021-02-22 | BEAM + Alemtuzumab Allo SCT | 01 | N | GEMTUZUMAB OZOGAMICIN | 101627133 |
| 240002637 | 240009616 | 1.77 | 21.35 | 03 | 2018-02-02 | 2018-02-02 | Cytarabine High Dose | 02 | null | TRIPLE INTRATHECAL | 100056675 |
| 240002649 | 240009618 | 1.6 | 79.4 | 03 | 2021-01-09 | 2021-01-09 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101317489 |
| 240002651 | 240009619 | 1.68 | 70.8 | 03 | 2017-11-14 | 2017-11-25 | null | 02 | null | VENETOCLAX | 100487371 |
| 240002654 | 240009621 | 1.82 | 83.6 | 03 | 2018-03-16 | 2018-08-11 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | N | N | AVAPRITINIB | 100976932 |
| 240002674 | 240009625 | 1.02 | 85.3 | Curative (C) | 2018-07-12 | 2018-07-22 | Venetoclax | 02 | null | ALL UKALL2011 MAINTENANCE | 101640580 |
| 240002676 | 240009626 | 0 | 28.25 | Palliative (P) | 2019-10-23 | 2019-10-24 | Cytarabine High Dose | 2 | N | BUSULFAN | 101764303 |
| 240002681 | 240009627 | 1.57 | 9 | Curative (C) | 2017-03-09 | 2017-03-16 | FLAG + Idarubicin | 02 | null | CNS HGG TEMOZOLOMIDE MAINTENANCE | 101392613 |
| 240002687 | 240009628 | 1.75 | 112.4 | null | null | 2020-03-22 | IVE | null | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 101805483 |
| 240002697 | 240009630 | 1.53 | 9.95 | null | 2018-12-28 | 2019-03-01 | ALL Interim Guide 2019 NOPHO B | 02 | null | CISPLATIN + CYTARABINE + ETOPOSIDE + RITUXIMAB | 100451551 |
| 240002702 | 240009631 | 1.69 | 9.95 | Curative (C) | 2019-10-05 | 2019-10-07 | Midostaurin | 02 | null | CHLORAMBUCIL + PROCARBAZINE + VINBLASTINE | 101607922 |
| 240002703 | 240009632 | 0 | 88.5 | null | 2020-02-04 | 2020-02-12 | DA-EPOCH-R | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100907534 |
| 240002704 | 240009633 | 1.54 | 79.2 | Curative (C) | null | 2021-01-22 | null | N | null | DABRAFENIB | 101247286 |
| 240002706 | 240009634 | 1.65 | 78.4 | Palliative (P) | 2022-05-10 | 2022-05-29 | FLAG + Idarubicin | 01 | N | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100290092 |
| 240002722 | 240009637 | 1.67 | 55 | Curative (C) | 2017-12-18 | 2018-02-21 | null | 02 | null | TRANSPLANT ALEMTUZUMAB | 100415407 |
| 240002723 | 240009638 | 1.75 | 86.95 | null | 2018-05-04 | 2018-05-09 | AML MyeChild 01 FLA | 02 | null | MIDOSTAURIN | 100079064 |
| 240002724 | 240009639 | 1.73 | 69.8 | Palliative (P) | 2017-03-30 | 2017-03-30 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE | 101660295 |
| 240002729 | 240009641 | 0 | 79.4 | Curative (C) | 2020-07-24 | 2022-04-08 | IBRUTINIB | 02 | N | CNS LOW GRADE GLIOMA VINBLASTINE | 101464129 |
| 240002737 | 240009644 | null | 96.5 | null | 2019-02-17 | 2019-03-11 | null | 02 | N | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100926406 |
| 240002739 | 240009645 | 0 | 17.7 | 03 | 2019-07-06 | 2019-07-30 | null | N | null | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 100407138 |
| 240002743 | 240009646 | 1.64 | 71.1 | Curative (C) | 2019-07-18 | 2020-03-24 | R Chlorambucil | 02 | null | CYTARABINE + DAUNORUBICIN | 100930548 |
| 240002754 | 240009647 | 1.78 | 76.3 | null | 2021-06-20 | 2021-06-30 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | null | ENZALUTAMIDE | 100630392 |
| 240002758 | 240009649 | 1.83 | 9.95 | Curative (C) | 2019-11-25 | 2019-11-25 | null | 02 | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 100059680 |
| 240002771 | 240009651 | 1.63 | 18.2 | null | null | 2020-09-15 | Dasatinib | 02 | null | BUSULFAN | 100305241 |
| 240002772 | 240009652 | 1.82 | 114 | Palliative (P) | 2018-12-13 | 2018-12-20 | Midostaurin | 02 | null | SORAFENIB | 101375285 |
| 240002775 | 240009653 | 1.85 | 11.75 | null | 2017-01-16 | 2017-01-19 | null | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101733692 |
| 240002777 | 240009655 | 1.84 | 51 | null | 2019-11-01 | 2019-11-09 | Obinutuzumab + Venetoclax | 02 | null | ANAGRELIDE | 101584198 |
| 240002786 | 240009656 | 0 | 52.9 | null | 2017-11-25 | 2017-11-26 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 01 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100601343 |
| 240002798 | 240009658 | 1.76 | 95.5 | Curative (C) | 2017-04-08 | 2017-05-09 | Venetoclax | null | null | NOT MATCHED | 100442675 |
| 240002800 | 240009659 | 1.67 | 75 | null | 2020-02-09 | 2020-02-21 | BEAM | 02 | null | AZACITIDINE + VENETOCLAX | 101636520 |
| 240002811 | 240009661 | 1.69 | 50.7 | Disease modification (D) | null | 2018-12-18 | FLAG + Idarubicin | 02 | N | RUXOLITINIB | 101321394 |
| 240002815 | 240009662 | 1.9 | 68 | 03 | 2020-02-25 | 2020-02-25 | null | 02 | null | FLAIR TRIAL | 100137843 |
| 240002817 | 240009664 | 1.6 | 74 | null | 2019-09-01 | 2019-09-08 | AML MyeChild 01 FLA | N | null | IMATINIB | 100255854 |
| 240002822 | 240009665 | 1.9 | 84.9 | null | 2018-04-12 | 2018-04-18 | null | N | null | AML MYECHILD 01 IT CYT | 100039410 |
| 240002826 | 240009666 | 1.74 | 8.9 | Disease modification (D) | 2021-06-22 | 2021-06-24 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101539970 |
| 240002829 | 240009667 | null | 10.4 | Adjuvant (A) | 2019-06-24 | 2019-06-26 | FLAG + Idarubicin | 02 | N | CYTARABINE + DAUNORUBICIN | 101182933 |
| 240002836 | 240009670 | 1.69 | 98.7 | 03 | 2021-03-14 | 2021-03-15 | IBRUTINIB | 02 | N | CYTARABINE HIGH DOSE | 101188698 |
| 240002844 | 240009673 | 1.52 | 21 | Palliative (P) | null | 2021-12-01 | FLAG + Idarubicin | null | null | IBRUTINIB | 100157504 |